Frontotemporal dementia parkinsonism: Clinical findings in a large Iranian family

Basiri, Keivan; Ansari, Behnaz; Meamar, Rokhsareh

Frontotemporal dementia parkinsonism: Clinical findings in a large Iranian family

Authors

¹ Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran

² Isfahan Neurosciences Research Center, Isfahan, Iran

Abstract

Frontotemporal dementia (FTD) is a group of neurodegenerative disorders characterized by atrophy of the frontal and temporal lobes. Clinical features suggestive of FTD include pre-senile onset before the age of 65, behavioral changes, social and interpersonal disinhibition, fluent and nonfluent aphasia, and loss of insight. FTD and parkinsonism linked to chromosome 17 (FTDP-17) was defined during the International Consensus Conference in Ann Arbor, Michigan in 1996. FTDP-17 is an autosomally dominant inherited condition. Most genotypic alterations do not correlate with clinical phenotypes. However, mutations affecting exon 10 splicing are associated with parkinsonism. In the present study, a male case with FTDP who presented with insidious onset of speech difficulty at a young age that was associated with signs of parkinsonism and a positive family history of FTD with MAPT gene mutation at exon 13 has been reported.

Keywords

References

1.	Cohn-Hokke PE, Elting MW, Pijnenburg YA, van Swieten JC. Genetics of dementia: Update and guidelines for the clinician. Am J Med Genet B Neuropsychiatr Genet 2012;159B:628-43.
2.	Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review. J Neurol Neurosurg Psychiatry 2011;82:476-86.
3.	Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011;134:2565-81.
4.	Rohrer JD, Warren JD. Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol 2011;24:542-9.
5.	Ferrari R, Hardy J, Momeni P. Frontotemporal dementia: From Mendelian genetics towards genome wide association studies. J Mol Neurosci 2011;45:500-15.
6.	Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
7.	Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005;4:771-80.
8.	Kumar-Singh S, Van Broeckhoven C. Frontotemporal lobar degeneration: Current concepts in the light of recent advances. Brain Pathol 2007;17:104-14.
9.	Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-8.
10.	McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowsk J. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-9.
11.	Whitwell JL, Przybelski SA, Weigand SD, Ivnik RJ, Vemuri P, Gunter JL, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: A cluster analysis study. Brain 2009;132:2932-46.
12.	Goedert M, Ghetti B, Spillantini MG. Frontotemporal dementia: Implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med 2012;2:a006254.
13.	Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 2012;8:423-34.
14.	Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 1998;95:13103-7.
15.	Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 59-splice-site mutations in tau with the inherited dementiaFTDP-17. Nature 1998;393:702-5.
16.	Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with preseniledementia. Proc Natl Acad Sci U S A 1998;95:7737-41.
17.	Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and Parkinsonism linked tochromosome 17: A consensus conference. Conference Participants. Ann Neurol 1997;41:706-15.
18.	Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, Delisle MB, et al. Clinical andgenetic studies of families with the tau N279K mutation(FTDP-17). Neurology 2002;59:1791-3.
19.	Ghetti B, Hutton M, Wszolek ZK. Frontotemporal dementia and parkinsonism linked to chromosome 17 associated with tau gene mutations (FTDP-17T). In Neurodegeneration: The molecular pathology of dementia and movement disorders Edited by: Basel DD. ISN Neuropath Press; 2003.
20.	Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001;22:89-107.

Advanced Biomedical Research